Literature DB >> 19261815

Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis.

Farhan Bangash1, Rajiv Agarwal.   

Abstract

BACKGROUND AND OBJECTIVES: Poor hypertension control observed in patients with chronic kidney disease (CKD) may in part be due to the suboptimal assessment of BP with clinic BP measurements alone. The goal of this meta-analysis was to estimate the prevalence and determinants of white-coat and masked hypertension in the adult CKD population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Articles reporting prevalence of masked and white-coat hypertension in patients with CKD were obtained from two major databases. We then performed a meta-analysis to derive pooled estimates of prevalence and determinants of these two conditions.
RESULTS: Among 980 patients with CKD identified in six studies, the overall prevalence of masked hypertension was 8.3% and of white-coat hypertension was 18.3%. More alarming, 40.4% of patients who had CKD and were thought to have normotension (or adequately treated hypertension) in fact had hypertension at home. Also 30.0% of patients who had CKD and were thought to have hypertension had normotension at home. The thresholds for classification of clinic and ambulatory BP as hypertensive strongly influenced the risk for diagnosis of masked hypertension in favor of white-coat hypertension.
CONCLUSIONS: Because clinic BP measurements alone lead to substantial misclassification in BP, we estimate that the prevalence of poorly controlled hypertension is likely less than currently estimated. Out-of-office BP monitoring may improve the management of hypertension in patients with CKD. Standardized definitions for the diagnosis of masked and white-coat hypertension would facilitate research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261815      PMCID: PMC2653652          DOI: 10.2215/CJN.05391008

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  25 in total

1.  Masked hypertension.

Authors:  Thomas G Pickering; Karina Davidson; William Gerin; Joseph E Schwartz
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.

Authors:  Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Peter W de Leeuw; Daniel A Duprez; Robert H Fagard; Peter J Gheeraert; Luc H Missault; Jacob J Braun; Roland O Six; Patricia Van Der Niepen; Eoin O'Brien
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

Review 3.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

4.  How common is white coat hypertension?

Authors:  T G Pickering; G D James; C Boddie; G A Harshfield; S Blank; J H Laragh
Journal:  JAMA       Date:  1988-01-08       Impact factor: 56.272

5.  Home blood pressure monitoring in CKD.

Authors:  Martin J Andersen; Wassim Khawandi; Rajiv Agarwal
Journal:  Am J Kidney Dis       Date:  2005-06       Impact factor: 8.860

6.  Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure.

Authors:  J E Liu; M J Roman; R Pini; J E Schwartz; T G Pickering; R B Devereux
Journal:  Ann Intern Med       Date:  1999-10-19       Impact factor: 25.391

7.  Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease.

Authors:  R Agarwal; M J Andersen
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

8.  Blood pressure control by home monitoring: meta-analysis of randomised trials.

Authors:  Francesco P Cappuccio; Sally M Kerry; Lindsay Forbes; Anna Donald
Journal:  BMJ       Date:  2004-06-11

9.  Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.

Authors:  Guillaume Bobrie; Gilles Chatellier; Nathalie Genes; Pierre Clerson; Laurent Vaur; Bernard Vaisse; Joël Menard; Jean-Michel Mallion
Journal:  JAMA       Date:  2004-03-17       Impact factor: 56.272

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  45 in total

1.  Epidemiology of chronic kidney disease among normotensives: but what is chronic kidney disease?

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-03-22       Impact factor: 10.190

2.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Authors:  Paul E Drawz; Arnold B Alper; Amanda H Anderson; Carolyn S Brecklin; Jeanne Charleston; Jing Chen; Rajat Deo; Michael J Fischer; Jiang He; Chi-Yuan Hsu; Yonghong Huan; Martin G Keane; John W Kusek; Gail K Makos; Edgar R Miller; Elsayed Z Soliman; Susan P Steigerwalt; Jonathan J Taliercio; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

3.  Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients.

Authors:  Rajiv Agarwal; Arjun D Sinha; Robert P Light
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

4.  Ambulatory BP Phenotypes and Their Association with Target Organ Damage and Clinical Outcomes in CKD.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-26       Impact factor: 8.237

5.  Much to Fear about MUCH.

Authors:  Rajiv Agarwal
Journal:  J Am Soc Nephrol       Date:  2020-10-06       Impact factor: 10.121

6.  Association between undiagnosed hypertension and microalbuminuria in South Asians without known diabetes.

Authors:  R W Major; M J Davies; W Crasto; L J Gray; D R Webb; K Khunti
Journal:  J Hum Hypertens       Date:  2014-08-14       Impact factor: 3.012

7.  Use of ambulatory blood pressure monitoring to guide hypertensive therapy.

Authors:  Amita Singh; Eugenia Gianos; Arthur Schwartzbard; Henry Black; Howard Weintraub
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-12

8.  The effect of measuring ambulatory blood pressure on nighttime sleep and daytime activity--implications for dipping.

Authors:  Rajiv Agarwal; Robert P Light
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

9.  A young patient with a family history of hypertension.

Authors:  Aldo J Peixoto
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

10.  Hypertension in chronic kidney disease: role of ambulatory blood pressure monitoring.

Authors:  Rene G VanDeVoorde; Mark M Mitsnefes
Journal:  Prog Pediatr Cardiol       Date:  2015-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.